Tag: Cancer

Study: COVID-19's impact on oncological surgery offers lessons for future crises

Editor's Note A scoping review of 15 studies reveals that the COVID-19 pandemic significantly disrupted oncological abdominal surgery (OAS), leading to postponed or canceled procedures, adoption of alternative treatment plans, and increased psychological stress among surgical teams. Published November 5 in the American Journal of Surgery, the findings emphasize the…

Read More

By: Matt Danford
November 22, 2024
Share

Study: Stool tests show promise in reducing colonoscopies for post-polypectomy colorectal cancer surveillance

Editor's Note Stool-based testing strategies could significantly reduce the number of colonoscopies required for post-polypectomy colorectal cancer (CRC) surveillance while maintaining equivalent long-term outcomes in cancer incidence and mortality, according to research published August 30 in Gastroenterology. Conducted in the Netherlands, the cross-sectional observational study compared three stool tests—multitarget stool…

Read More

By: Matt Danford
November 1, 2024
Share

Study: Wearable devices improve postoperative physical activity in lung cancer patients

JAMA (healthcare publication) Network logo

Editor's Note In a recent study, lung cancer patients using wearable devices showed significantly improved postoperative physical activity and pulmonary function as well as reduced symptoms such as dyspnea and pain. Published September 20 in Jama Network Open, the study compared 74 patients in the intervention group (who used wearable…

Read More

By: Matt Danford
October 16, 2024
Share

Algorithm enhances decision-making on intermediate-stage liver cancer surgery, treatment

Editor's Note An algorithm developed by researchers at Duke University Medical Centre is designed to assist patients diagnosed with intermediate-stage liver cancer in making decisions about surgery, according to an October 9 report in News Medical Life Sciences. Known as the Modified Metroticket, this tool predicts overall survival and recurrence-free…

Read More

By: Matt Danford
October 10, 2024
Share

Immunotherapy’s FDA approval expected to improve lung cancer treatment

Editor's Note The US Food & Drug Administration (FDA) has approved immunotherapy durvalumab for perioperative treatment of resectable non-small cell lung cancer (NSCLC), according to an August 15 announcement. The approval is for durvalumab (Imfinzi, AstraZeneca) in combination with platinum-based chemotherapy as a neoadjuvant treatment, followed by durvalumab alone as…

Read More

By: Matt Danford
August 22, 2024
Share

Study: Starting adjuvant chemotherapy more than 6 weeks after surgery worsens colorectal cancer survival

Editor's Note A post hoc analysis of the SCOT phase 3 randomized clinical trial reveals that initiating adjuvant chemotherapy more than 6 weeks after surgery is linked to worse disease-free survival (DFS) in patients with high-risk stage II and stage III colorectal cancer. Published June 12 in JAMA Surgery, the…

Read More

By: Matt Danford
August 20, 2024
Share

EHR ‘nudge’ reduces unnecessary axillary surgery in older breast cancer patients

JAMA (healthcare publication) Network logo

Editor's Note An electronic health record (EHR)-based nudge could significantly reduce low-value axillary surgeries in older women with early-stage breast cancer, researchers reported July 17 in JAMA Surgery. Conducted across eight clinical settings, the initiative significantly cut the rates of low-value sentinel lymph node biopsies (SLNB) by nearly 50% over…

Read More

By: Matt Danford
August 5, 2024
Share

Voice-restoring larynx transplant shows progress for rare cancer treatment

Editor's Note A Massachusetts man, Marty Kedian, regained his voice after a pioneering larynx transplant at the Mayo Clinic in Arizona, The Associated Press (AP) reported July 9. According to the article, Kedian is only the third person in the U.S. to receive a total larynx transplant and the first…

Read More

By: Matt Danford
July 17, 2024
Share

Reassessing colonoscopy surveillance: Early- vs average-onset colorectal cancer

Editor's Note Early-onset colorectal cancer (EO-CRC), diagnosed before age 50, is increasing in incidence worldwide. Despite existing postoperative colonoscopy surveillance strategies, the optimal intervals for EO-CRC patients are unclear due to limited long-term data. This study, titled “Early-onset Colorectal Cancer Patients Do Not Require Shorter Intervals for Post-surgical Surveillance Colonoscopy”…

Read More

By: Tarsilla Moura
June 26, 2024
Share

AI outperforms radiologists in detecting clinically significant prostate cancer

Editor's Note In a recent study, an artificial intelligence (AI) system detected more clinically significant prostate cancers and fewer indolent cancers than human radiologists reading MRIs, MedPage today reported June 13. The MedPage report covers a study published in Lancet Oncology that, according to researchers, “provided evidence that AI systems,…

Read More

By: Matt Danford
June 26, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat